These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7316635)

  • 1. [Phospholipidosis of the rat lung following administrations of chlorimipramine].
    Gremigni D; Vannelli G; Sgaragli G; Della Corte L
    Arch Ital Anat Embriol; 1981; 86(1-2):37-53. PubMed ID: 7316635
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat.
    Sgaragli GP; Della Corte L; Gremigni D
    Pharmacol Res Commun; 1983 Mar; 15(3):231-46. PubMed ID: 6856656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phospholipidosis induced by chlorimipramine in rat lung].
    Gremigni D; Vannelli G; Sgaragli GP; Mengazzini I
    Boll Soc Ital Biol Sper; 1980 May; 56(10):1078-82. PubMed ID: 7448010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations [proceedings].
    Della Corte L; Gremigni D; Megazzini I; Mobilio R; Sgaragli GP
    Br J Pharmacol; 1979 Nov; 67(3):449P-450P. PubMed ID: 497566
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of lung lipids following inhalation of quartz.
    Heppleston AG; Fletcher K; Wyatt I
    Experientia; 1972 Aug; 28(8):938-9. PubMed ID: 4342514
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
    Tilmant K; Gerets HH; Dhalluin S; Hanon E; Depelchin O; Cossu-Leguille C; Vasseur P; Atienzar FA
    Toxicol In Vitro; 2011 Oct; 25(7):1414-24. PubMed ID: 21515356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat].
    Lageron A; Saffroy M
    Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced phospholipid storage disease].
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Dtsch Med Wochenschr; 1973 Aug; 98(35):1616 passim. PubMed ID: 4150413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-induced phospholipidosis - experimental and clinical aspects].
    Nässberger L
    Lakartidningen; 1982 Aug; 79(32-33):2777-9. PubMed ID: 7144360
    [No Abstract]   [Full Text] [Related]  

  • 14. The ultrastructure of rat lung changes induced by an anorectic drug (chlorphentermine).
    Lüllmann-Rauch R; Reil GH; Rossen E; Seiler KU
    Virchows Arch B Cell Pathol; 1972; 11(2):167-81. PubMed ID: 4343045
    [No Abstract]   [Full Text] [Related]  

  • 15. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864.
    Rudmann DG; McNerney ME; VanderEide SL; Schemmer JK; Eversole RR; Vonderfecht SL
    Toxicol Pathol; 2004; 32(3):326-32. PubMed ID: 15204974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary phospholipidosis caused by 4.4'-diethylaminoethoxy hexestrol].
    Shikata T
    Rinsho Byori; 1973 May; 21(5):389-94. PubMed ID: 4738035
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assays and biomarkers for drug-induced phospholipidosis.
    Monteith DK; Morgan RE; Halstead B
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.